Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,481 | 294 | 84.5% |
| Travel and Lodging | $811.46 | 4 | 10.6% |
| Education | $226.41 | 8 | 3.0% |
| Consulting Fee | $153.68 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $2,290 | 32 | $0 (2020) |
| Astellas Pharma US Inc | $1,550 | 84 | $0 (2021) |
| COLOPLAST CORP | $663.09 | 35 | $0 (2024) |
| AbbVie Inc. | $345.38 | 15 | $0 (2021) |
| BOSTON SCIENTIFIC CORPORATION | $324.78 | 15 | $0 (2021) |
| Antares Pharma, Inc. | $253.51 | 12 | $0 (2022) |
| PROCEPT BioRobotics Corporation | $243.47 | 2 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $239.94 | 17 | $0 (2021) |
| PFIZER INC. | $209.36 | 15 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $201.05 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $147.77 | 7 | Sumitomo Pharma America, Inc. ($62.99) |
| 2023 | $274.95 | 9 | Dendreon Pharmaceuticals LLC ($104.86) |
| 2022 | $96.13 | 4 | Coloplast Corp ($71.21) |
| 2021 | $797.61 | 45 | Astellas Pharma US Inc ($251.18) |
| 2020 | $508.50 | 26 | Astellas Pharma US Inc ($165.36) |
| 2019 | $1,599 | 73 | Astellas Pharma US Inc ($353.78) |
| 2018 | $1,276 | 64 | Astellas Pharma US Inc ($360.05) |
| 2017 | $2,973 | 80 | NeoTract Inc. ($1,822) |
All Payment Transactions
308 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: UROLOGY | ||||||
| 05/03/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Oncology | ||||||
| 04/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: UROLOGY | ||||||
| 03/20/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Continence Care | ||||||
| 03/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: UROLOGY | ||||||
| 02/14/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Continence Care | ||||||
| 02/07/2024 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $25.39 | General |
| 12/06/2023 | Hollister Incorporated | Infyna Chic (Device), Onli, VaPro | Food and Beverage | Cash or cash equivalent | $17.07 | General |
| Category: Continence Care | ||||||
| 11/29/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Urology | ||||||
| 11/27/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $104.86 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/09/2023 | ConvaTec Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: CONTINENCE CARE | ||||||
| 10/05/2023 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 09/07/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: Urology | ||||||
| 08/24/2023 | Hollister Incorporated | Infyna Chic (Device), Onli, VaPro | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: Continence Care | ||||||
| 04/11/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Prostate Cancer | ||||||
| 01/18/2023 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Continence Care | ||||||
| 09/13/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Continence Care | ||||||
| 04/13/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 03/07/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Continence Care | ||||||
| 02/11/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $30.37 | General |
| Category: Continence Care | ||||||
| 12/08/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 11/10/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 09/27/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: UROLOGY | ||||||
| 09/21/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Testosterone Replacement Therapy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 259 | 348 | $43,265 | $13,331 |
| 2022 | 4 | 99 | 106 | $11,076 | $3,971 |
| 2021 | 26 | 1,876 | 2,619 | $369,521 | $135,150 |
| 2020 | 22 | 2,768 | 3,699 | $506,433 | $155,547 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 82 | $21,484 | $6,460 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 41 | $7,257 | $2,331 | 32.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 11 | 11 | $4,422 | $2,022 | 45.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $6,000 | $1,774 | 29.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 47 | 63 | $3,150 | $449.12 | 14.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 91 | 136 | $952.00 | $295.24 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 25 | $6,550 | $2,489 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 20 | $3,540 | $1,281 | 36.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 43 | 48 | $336.00 | $105.60 | 31.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 12 | 13 | $650.00 | $95.04 | 14.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 370 | 470 | $79,572 | $44,623 | 56.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 297 | 348 | $44,330 | $21,403 | 48.3% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 75 | 108 | $63,180 | $19,366 | 30.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 16 | 93 | $73,098 | $14,385 | 19.7% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2021 | 16 | 209 | $15,675 | $7,334 | 46.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 44 | 44 | $11,572 | $5,672 | 49.0% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2021 | 16 | 49 | $5,390 | $3,440 | 63.8% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 546 | 775 | $13,175 | $3,099 | 23.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 20 | $4,829 | $2,723 | 56.4% |
| 76872 | Ultrasound of pelvic region through rectum | Office | 2021 | 18 | 19 | $5,605 | $2,066 | 36.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2021 | 86 | 86 | $5,074 | $1,582 | 31.2% |
| 52332 | Insertion of stent in urinary duct (ureter) using an endoscope | Facility | 2021 | 13 | 13 | $18,200 | $1,109 | 6.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 13 | $1,300 | $877.98 | 67.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $2,035 | $732.87 | 36.0% |
| 51700 | Bladder irrigation and/or instillation | Office | 2021 | 11 | 12 | $3,264 | $713.46 | 21.9% |
About Dr. Thomas Phillips, MD
Dr. Thomas Phillips, MD is a Urology healthcare provider based in Matthews, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801839378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Phillips, MD has received a total of $7,673 in payments from pharmaceutical and medical device companies, with $147.77 received in 2024. These payments were reported across 308 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($6,481).
As a Medicare-enrolled provider, Phillips has provided services to 5,002 Medicare beneficiaries, totaling 6,772 services with total Medicare billing of $307,998. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Matthews, NC
- Active Since 06/13/2006
- Last Updated 05/15/2008
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1801839378
Products in Payments
- Urolift - UL400 (Device) $1,822
- XTANDI (Drug) $849.97
- UroLift (Device) $468.10
- SPEEDICATH (Device) $272.22
- AquaBeam Robotic System (Device) $243.47
- XIAFLEX (Biological) $239.94
- Myrbetriq (Drug) $225.26
- PROVENGE (Drug) $220.42
- VESICARE (Drug) $208.19
- MYRBETRIQ (Drug) $182.76
- CONTINENCE CARE (Device) $179.48
- LITHOVUE (Device) $150.42
- XYOSTED (Drug) $148.66
- Lupron Depot (Drug) $143.31
- Androgel (Drug) $123.09
- SpeediCath (Device) $122.70
- ZYTIGA (Drug) $115.31
- GEMTESA (Drug) $110.62
- ELIGARD (Drug) $104.51
- Xtandi (Drug) $94.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Matthews
Dr. Roger Yau, M.d, M.D
Urology — Payments: $12,414
Dr. Bradley Weisner, M.d, M.D
Urology — Payments: $10,403
Liliya Velet, Md, MD
Urology — Payments: $7,517
Dr. Christopher Ritchie, Md, MD
Urology — Payments: $3,262
Samuel Dupuy, M.d, M.D
Urology — Payments: $13.26